
1. Genesis. 2005 Apr;41(4):165-70.

Temporally controlled targeted somatic mutagenesis in skeletal muscles of the
mouse.

Schuler M(1), Ali F, Metzger E, Chambon P, Metzger D.

Author information: 
(1)Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre
National de la Recherche Scientifique, Institut National de la Santé et de la
Recherche Médicale, Université Louis Pasteur, Collège de France, Illkirch-Cedex, 
France.

To generate temporally controlled targeted somatic mutations selectively and
efficiently in skeletal muscles, we established a transgenic HSA-Cre-ER(T2) mouse
line in which the expression of the tamoxifen-dependent Cre-ER(T2) recombinase is
under the control of a large genomic DNA segment of the human skeletal muscle
alpha-actin gene, contained in a P1-derived artificial chromosome. In this
transgenic line Cre-ER(T2) is selectively expressed in skeletal muscles, and
Cre-ER(T2)-mediated alteration of LoxP flanked (floxed) target genes is skeletal 
muscle-specific and strictly tamoxifen-dependent. HSA-Cre-ER(T2) mice should be
of great value to analyze gene function in skeletal muscles, and to establish
animal models of human skeletal muscle disorders.

Copyright (c) 2005 Wiley-Liss, Inc.

DOI: 10.1002/gene.20107 
PMID: 15789425  [Indexed for MEDLINE]

